Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alexander N Shoushtari
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
147 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ottawa Hospital and Cancer Center-General Campus
Ottawa, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Sutter Auburn Faith Hospital
Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Keck Medicine of Usc Koreatown
Los Angeles, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Usc Norris Oncology/hematology-Newport Beach
Newport Beach, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Mills Health Center
San Mateo, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Sutter Pacific Medical Foundation
Santa Rosa, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- the Melanoma and Skin Cancer Institute
Englewood, Colorado, United States
- Um Sylvester Comprehensive Cancer Center at Aventura
Aventura, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Plantation
Plantation, Florida, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Saint Alphonsus Cancer Care Center-Caldwell
Caldwell, Idaho, United States
- Kootenai Health - Coeur D'Alene
Coeur d'Alene, Idaho, United States
- Saint Alphonsus Cancer Care Center-Nampa
Nampa, Idaho, United States
- Kootenai Clinic Cancer Services - Post Falls
Post Falls, Idaho, United States
- Kootenai Clinic Cancer Services - Sandpoint
Sandpoint, Idaho, United States
- Rush-Copley Medical Center
Aurora, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Northwestern Medicine Cancer Center Kishwaukee
DeKalb, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Aug 2022
- Primary completion
- 1 Sept 2026
- Completion
- 1 Sept 2026
- Last update posted
- 24 Jun 2026
- Registered enrollment
- 101
- Registry id
- NCT05111574
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.